Published May 31, 2008 | Version v1
Journal article

HIV-1 integrase inhibitors as new components of antiviral therapy

  • 1. A. N. Belozersky Institute of Physico-Chemical Biology, M. V. Lomonosov Moscow State University, Moscow (Russian Federation)
  • 2. Department of Chemistry, M.V. Lomonosov Moscow State University, Moscow (Russian Federation)

Description

Structural and functional features of HIV-1 integrase are considered and the state of the art in the quest for effective inhibitors of this enzyme is reported. The major classes of integrase inhibitors with known mechanisms of action as well as their in vitro and in vivo inhibitory activities are presented

Availability note (English)

Available from http://dx.doi.org/10.1070/RC2008v077n05ABEH003779

Additional details

Publishing Information

Journal Title
Russian Chemical Reviews (Print)
Journal Volume
77
Journal Issue
5
Journal Page Range
p. 421-434
ISSN
0036-021X

INIS

Country of Publication
United Kingdom
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
39105027
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
AIDS VIRUS; ENZYMES; IN VITRO; IN VIVO; THERAPY
Descriptors DEC
MEDICINE; MICROORGANISMS; ORGANIC COMPOUNDS; PARASITES; PROTEINS; VIRUSES